drugset / Trial / NCT05745311
Study of the KPCXM18 Injection for Treatment of Acute Ischemic Stroke
RandomizedParallel-groupTriple-blindTreatment
Summary
This study is a multicenter, randomized, double-blind, parallel, placebo-controlled trial design to evaluate the efficacy and safety of the KPCXM18 injection at different doses for the treatment of acute ischemic stroke and its PK/PD characteristics in patients.
Timeline
- Start
- 2023-03-01
- Primary completion
- 2024-05-01
- Completion
- 2024-07-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | KPCXM18 | Unknown | 20 mg | Intravenous |
| Subject | KPCXM18 | Unknown | 60 mg | Intravenous |
| Subject | KPCXM18 | Unknown | 100 mg | Intravenous |